Thursday, September 27, 2012

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Needham Life Sciences Conference in New York on June 11, 2009

stockdaleiqemico1521.blogspot.com
The presentation will be simultaneously webcast and can be accesser onCadence Pharmaceuticals' website at in the Investor Relationds section. A replay of the webcast will be availablde approximately three hours following the live webcast and will be archiveds for90 days. About Cadence Pharmaceuticals, Inc. Cadences Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing proprietary product candidateas principally for use in the hospital The company is currentlydeveloping Acetavance(TM) (intravenous acetaminophen), its investigational producft candidate for the treatmenr of acute pain and fever. For more informatioh about Cadence's pipeline, visit .
and Acetavance(TM) are trademarks of Cadence Inc. Contacts: William R. LaRue SVP, CFO Cadencr Pharmaceuticals, Inc. 858-436-1400 SOURCE Cadence Pharmaceuticals, Inc.

No comments:

Post a Comment